About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
American Journal of Clinical and Experimental Urology
›
top-articles
American Journal of Clinical and Experimental Urology
0.4
(top 100%)
impact factor
228
(top 50%)
papers
1.4K
(top 50%)
citations
18
(top 50%)
h
-index
0.4
(top 100%)
extended IF
238
all documents
1.5K
doc citations
31
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Lipid metabolism in prostate cancer
American Journal of Clinical and Experimental Urology
2014
107
2
Neuroendocrine differentiation of prostate cancer: a review
American Journal of Clinical and Experimental Urology
2014
107
3
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma
American Journal of Clinical and Experimental Urology
2014
52
4
Drug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategies
American Journal of Clinical and Experimental Urology
2015
49
5
Wnt signaling in castration-resistant prostate cancer: implications for therapy
American Journal of Clinical and Experimental Urology
2014
46
6
Infections and inflammation in prostate cancer
American Journal of Clinical and Experimental Urology
2013
42
7
Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation
American Journal of Clinical and Experimental Urology
2014
38
8
Proinflammatory cytokine interleukin-6 in prostate carcinogenesis
American Journal of Clinical and Experimental Urology
2014
37
9
Androgen action in prostate function and disease
American Journal of Clinical and Experimental Urology
2018
37
10
Biomarkers for bladder cancer management: present and future
American Journal of Clinical and Experimental Urology
2014
36
11
Mechanisms of hemorrhagic cystitis
American Journal of Clinical and Experimental Urology
2014
34
12
HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century
American Journal of Clinical and Experimental Urology
2015
31
13
Cytoskeleton targeting value in prostate cancer treatment
American Journal of Clinical and Experimental Urology
2014
27
14
Adenocarcinoma of the urinary bladder
American Journal of Clinical and Experimental Urology
2015
26
15
TBL1XR1 in physiological and pathological states
American Journal of Clinical and Experimental Urology
2015
24
16
A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds
American Journal of Clinical and Experimental Urology
2014
23
17
PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
American Journal of Clinical and Experimental Urology
2016
22
18
Prostate cancer progression and metastasis: potential regulatory pathways for therapeutic targeting
American Journal of Clinical and Experimental Urology
2014
18
19
Molecular mechanisms involving prostate cancer racial disparity
American Journal of Clinical and Experimental Urology
2017
18
20
Vicious cycle of TGF-β signaling in tumor progression and metastasis
American Journal of Clinical and Experimental Urology
2014
17
21
PI-3 kinase p110β: a therapeutic target in advanced prostate cancers
American Journal of Clinical and Experimental Urology
2014
16
22
Role of PARP-1 in prostate cancer
American Journal of Clinical and Experimental Urology
2015
14
23
Immune modulatory functions of EZH2 in the tumor microenvironment: implications in cancer immunotherapy
American Journal of Clinical and Experimental Urology
2019
14
24
Prostate epithelial stem and progenitor cells
American Journal of Clinical and Experimental Urology
2014
13
25
PD-L1 instead of PD-1 status is associated with the clinical features in human primary prostate tumors
American Journal of Clinical and Experimental Urology
2019
13
26
Predictive value of pseudouridine in prostate cancer
American Journal of Clinical and Experimental Urology
2019
13
27
Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production
American Journal of Clinical and Experimental Urology
2013
12
28
Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer
American Journal of Clinical and Experimental Urology
2014
12
29
Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors
American Journal of Clinical and Experimental Urology
2018
12
30
MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer
American Journal of Clinical and Experimental Urology
2014
11
31
Emerging players in prostate cancer: long non-coding RNAs
American Journal of Clinical and Experimental Urology
2014
11
32
Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion
American Journal of Clinical and Experimental Urology
2019
11
33
Single-cell RNA-Seq analysis identifies a putative epithelial stem cell population in human primary prostate cells in monolayer and organoid culture conditions
American Journal of Clinical and Experimental Urology
2019
11
34
The dysfunctional lipids in prostate cancer
American Journal of Clinical and Experimental Urology
2019
11
35
Bioinformatics analyses of publicly available NEPCa datasets
American Journal of Clinical and Experimental Urology
2019
11
36
Anti-androgen resistance in prostate cancer cells chronically induced by interleukin-1β
American Journal of Clinical and Experimental Urology
2013
10
37
Androgen receptor coactivators that inhibit prostate cancer growth
American Journal of Clinical and Experimental Urology
2014
10
38
Estrogen receptors in prostate development and cancer
American Journal of Clinical and Experimental Urology
2014
10
39
Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue
American Journal of Clinical and Experimental Urology
2014
10
40
Role of pre- ( and ) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma
American Journal of Clinical and Experimental Urology
2019
10
41
TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathways
American Journal of Clinical and Experimental Urology
2014
9
42
Therapeutic challenges in renal cell carcinoma
American Journal of Clinical and Experimental Urology
2015
9
43
Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent
American Journal of Clinical and Experimental Urology
2015
9
44
Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer
American Journal of Clinical and Experimental Urology
2018
9
45
Urinary metabolites for urological cancer detection: a review on the application of volatile organic compounds for cancers
American Journal of Clinical and Experimental Urology
2019
9
46
Splicing variants of androgen receptor in prostate cancer
American Journal of Clinical and Experimental Urology
2013
8
47
Hypofractionated radiation therapy for prostate cancer: biologic and technical considerations
American Journal of Clinical and Experimental Urology
2014
8
48
The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years
American Journal of Clinical and Experimental Urology
2014
8
49
Organization of sperm DNA by the nuclear matrix
American Journal of Clinical and Experimental Urology
2018
8
50
Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancer
American Journal of Clinical and Experimental Urology
2019
8
site/software ©
exaly
; All materials licenced under
CC by-SA
.